Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
1.32M
-
Shares change
-
-32.5K
-
Total reported value, excl. options
-
$12.5M
-
Value change
-
-$436K
-
Number of buys
-
17
-
Number of sells
-
-17
-
Price
-
$9.45
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2016
41 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2016.
XBiotech Inc. - Common Shares, no par value (XBIT) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.32M shares
of 30.8M outstanding shares and own 4.29% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (518K shares), VANGUARD GROUP INC (397K shares), NORTHERN TRUST CORP (44.7K shares), GEODE CAPITAL MANAGEMENT, LLC (41.2K shares), STATE STREET CORP (40.6K shares), ALPS ADVISORS INC (36.2K shares), BlackRock Institutional Trust Company, N.A. (34K shares), M Holdings Securities, Inc. (25.8K shares), ProShare Advisors LLC (24.3K shares), and SYNOVUS FINANCIAL CORP (17.7K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.